Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients
PaperCitations, authors & open-access status
Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 9 citations, 2020 year and closed oa status.
9
Citations
2020
Year
closed
OA Status